deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT04334993

Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study

A Phase 2, Multicenter, Single Arm Trial to Assess the Safety and Efficacy of a Pediatric Approach to for Young Adults With Acute Lymphoblastic Leukemia With Blinatumomab Therapy for High-risk Patients Prior to Allogeneic Transplantation

Sponsor: Israeli Medical Association

Conditions High-Risk Cancer Philadelphia-Negative ALL
Interventions Blinatumomab
Updated 7 times since 2020 Last updated: May 6, 2021 Started: Jan 1, 2021 Primary completion: May 1, 2023 Completion: May 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04334993, this PHASE2 trial focuses on High-Risk Cancer and Philadelphia-Negative ALL and remains ongoing. Sponsored by Israeli Medical Association, it has been updated 7 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~May 2020 – ~Sep 2020 · 4 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotRecruiting~Jun 2025 – present · 13 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Jun 2025 — Present [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  2. Sep 2024 — Jun 2025 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Jun 2021 — Jul 2024 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2021 — Jun 2021 [monthly]

    Not Yet Recruiting PHASE2

▶ Show 2 earlier versions

  1. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  2. May 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Israeli Medical Association
Data source: Israeli Medical Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations